Donation

Designed to serve as consistent references in a concise manner, the IMF’s Tip Cards cover key topics, including treatment and care issues of interest to patients and caregivers. All of the Tip cards below can be downloaded, free of charge.

Abecma® (idecabtagene vicleucel, “ide-cel”) is the first-in-class B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell…
This Tip Card covers the importance of treatment adherence.
Alkylators are chemotherapy drugs that interfere with the DNA replication process, causing cell death as a result.
When confronted with a diagnosis of multiple myeloma, consult with a myeloma specialist about treatment options.
Bispecific antibody therapies are a combination of two immunotherapy approaches in one drug, used to treat multiple myeloma.
A support network is a group of people who can assist during times of need. A support network is helpful whether or not you have a single go-to care…
Care partners walk alongside their loved ones to help them live well with myeloma.
Carvykti™ (ciltacabtagene autoleucel, or “cilta-cel”) Tip Card discusses this FDA-approved immunotherapy for relapsed or refractory multiple myeloma…
Both Darzalex (daratumumab) and Darzalex Faspro® (daratumumab plus hyaluronidase-fihj) are available as monotherapy and as part of combination…
This Tip Card covers early diagnosis and warning signs of multiple myeloma.
This Tip Card discusses Empliciti (elotuzumab) for the treatment of multiple myeloma.
Making Myeloma Matter. Addressing the increased risk of multiple myeloma diagnosis in African Americans.
This Tip Card discusses Kyprolis (carfilzomib) for the treatment of multiple myeloma.
Download this Tip Card to gain information on how to manage immunosuppression.
Multiple myeloma discussion tool developed with myeloma patients, caregivers, support group leaders, and the IMF Nurse Leadership Board.
This Tip Card discusses Ninlaro (ixazomib) for the treatment of multiple myeloma.
This Tip Card discusses Pomalyst (pomalidomide) for the treatment of multiple myeloma.
Sarclisa is a novel monoclonal antibody directed against the CD38 receptor on the surface of myeloma cells.

The triplet VRd regimen is approved in the United States and in the European Union for patients with previously untreated myeloma who are…

This information is in an easy-to-carry format and covers key treatments and care issues.
Xpovio (selinexor) is a nuclear export inhibitor to treat multiple myeloma
This Tip Card provides practical advice on how to protect your medical records.

We Thank Our Sponsors:
 Johnson & Johnson, Sanofi, and Pfizer.

Give Where Most Needed